发明名称 Substance specific to human PD-1
摘要 The present invention relates to a substance specific to human PD-1 comprising a part that recognizes human PD-1, a part that recognizes a membrane protein in cell membrane of human PD-1-expressing cells, and linkers. Since the substance specific to human PD-1 selectively can recognize human PD-1 and a membrane protein on cell membrane of human PD-1-expressing cells and can transmit inhibitory signal of human PD-1, it is useful for therapy and/or prevention of diseases caused by immunopathy.
申请公布号 US8951518(B2) 申请公布日期 2015.02.10
申请号 US201213548807 申请日期 2012.07.13
申请人 Ono Pharmaceutical Co., Ltd. 发明人 Honjo Tasuku;Shibayama Shiro;Takeda Kazuhiko;Matsuo Masayoshi;Yoshida Takao;Miyamoto Masakazu
分类号 A61K39/395;C07K16/28;A61K39/00 主分类号 A61K39/395
代理机构 Sughrue Mion, PLLC 代理人 Sughrue Mion, PLLC
主权项 1. A preventive and/or therapeutic method for insulin dependent diabetes mellitus, comprising administering an effective amount of a bispecific antibody to an insulin dependent diabetes mellitus patient, wherein the bispecific antibody comprises the following parts; (a) VH region of anti-human PD-1 antibody; (b) VL region of anti-human CD3 antibody; (c) VH region of said anti-human CD3 antibody; and (d) VL region of said anti-human PD-1 antibody, and wherein each of said part is linked by peptide linkers, so that said part (a) can bind to human PD-1 together with said part (d) and said part (c) can bind to human CD3 together with said part (b).
地址 Osaka JP